Aspire Financial Statements From 2010 to 2026
| ASBP Stock | 0.05 0.01 11.58% |
Check Aspire BioPharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspire BioPharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aspire financial statements analysis is a perfect complement when working with Aspire BioPharma Valuation or Volatility modules.
Check out the analysis of Aspire BioPharma Correlation against competitors. Aspire BioPharma Company Shares Owned By Insiders Analysis
Aspire BioPharma's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Aspire BioPharma Shares Owned By Insiders | 13.96 % |
Most of Aspire BioPharma's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aspire BioPharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 13.961% of Aspire BioPharma are shares owned by insiders. This is 8.03% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 14.18) industry. The shares owned by insiders for all United States stocks is 38.36% lower than that of the firm.
Aspire BioPharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aspire BioPharma's current stock value. Our valuation model uses many indicators to compare Aspire BioPharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aspire BioPharma competition to find correlations between indicators driving Aspire BioPharma's intrinsic value. More Info.Aspire BioPharma is rated below average in return on asset category among its peers. It is rated second in operating margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Aspire BioPharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Aspire BioPharma Financial Statements
Aspire BioPharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Aspire BioPharma investors may analyze each financial statement separately, they are all interrelated. The changes in Aspire BioPharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aspire BioPharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Pair Trading with Aspire BioPharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspire BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspire BioPharma will appreciate offsetting losses from the drop in the long position's value.Moving against Aspire Stock
| 0.9 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.77 | VWAGY | Volkswagen AG 110 | PairCorr |
| 0.74 | VLKAF | Volkswagen AG | PairCorr |
| 0.7 | JNJ | Johnson Johnson Earnings Call This Week | PairCorr |
| 0.66 | PFE | Pfizer Inc Aggressive Push | PairCorr |
The ability to find closely correlated positions to Aspire BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspire BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspire BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspire BioPharma to buy it.
The correlation of Aspire BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspire BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspire BioPharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspire BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Aspire Stock Analysis
When running Aspire BioPharma's price analysis, check to measure Aspire BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma is operating at the current time. Most of Aspire BioPharma's value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma's price. Additionally, you may evaluate how the addition of Aspire BioPharma to your portfolios can decrease your overall portfolio volatility.